Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
24.00
Ask:
26.00
Spread: 2.00 (8.333%)
Market Cap: £27.00m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

AGM Statement

31 Jul 2014 07:00

RNS Number : 7960N
Elektron Technology PLC
31 July 2014
Β 

ο»Ώ

31 July 2014

Β 

Elektron Technology plc

(AIM: EKT, "Elektron" or "the Company" or the "Group")

Β 

AGM Statement

Β 

Chairman Keith Daley will make the following statement at Elektron's AGM later today.

Β 

"The recent successful fundraise of Β£3.3m (before expenses) will allow us to focus better on further improving trading performance, on delivering the necessary returns from investment in new products and on optimising those from existing products. This will create the conditions for organic growth which has eluded the business for several years.

Β 

"Revenues in the six months ending 31 July 2014 excluding the effect of disposals are expected to be at slightly lower than the same period last year, mainly due to the strategic decision to rationalise the Group's low margin factored products sold to the NHS.

Β 

"As previously announced, there has been some destocking by Connectivity customers, following substantial improvements during the last nine months to the Group's on time delivery performance. However, sales from new products are increasingly offsetting the decline in the legacy portfolio and are expected to be significantly ahead of the corresponding period last year.

Β 

"The Group's trading performance has improved as a result of both selective price increases and reductions in Selling, General & Administrative overheads implemented in the second half of last financial year. Operational exceptional costs have now been eliminated, although the Interim Results will include exceptional costs of approximately Β£0.8m to cover the fund raise, renegotiation of bank facilities including debt advisory and the Strategic Alternatives process - all of which we successfully completed in the first half.

Β 

"The Group saw a significant cash inflow as a result of the fund raise, improved working capital control and operating performance. Net Debt on 31 July 2014 is expected to be below Β£5.0m compared with Β£8.0m at 31 January 2014."

Β 

The Group expects to announce its results for the half year to 31 July 2014 on 11 September 2014.

Β 

For further information:

Β 

Elektron Technology www.elektron-technology.com

+44 (0) 1223 371 000

John Wilson - Chief Executive Officer

Andy Weatherstone - Chief Financial Officer

finnCap (Nominated Adviser, Financial Adviser and Broker)

+44 (0)20 7220 0500

Ed Frisby/Ben Thompson (Corporate Finance)

Malar Velaigam (Corporate Broking)

Instinctif Partners

+44 (0)20 7457 2020

Adrian Duffield/Kay Larsen

Β 

Notes to Editors

Β 

Elektron conceives designs and markets innovative engineered products and services for businesses at its technology hub in Cambridge. It has a multi skilled team of engineers and product line specialists focused on the opportunities created by disruptive global trends in the following areas:

Β 

Β· New waves of "aware" business applications: Internet of Things

Β· Demand for ubiquitous power and data: Connectivity Solutions

Β· Growth in high precision manufacture: Nano-positioning

Β· Healthcare for the ageing population: Ophthalmology

Β· Connected customer experiences and service delivery: E-Commerce and E-Service

Β 

In addition it owns a portfolio of well-established products and brands which provide customer access and feedback.

Β 

Elektron Technology is headquartered in Cambridge and its shares are admitted to trading on the AIM market of the London Stock Exchange.

Β 

Forward looking statements

Β 

Statements contained in this AGM Statement are based on the knowledge and information available to the Company's directors at the date it was prepared and therefore the facts stated and views expressed may change after that date. By their nature, the statements concerning the risks and uncertainties facing the Company in this AGM Statement involve uncertainty since future events and circumstances can cause results and developments to differ materially from those anticipated.Β To the extent that this AGM Statement contains any statement dealing with any time after the date of its preparation such statement is merely predictive and speculative as it relates to events and circumstances which are yet to occur. The Company undertakes no obligation to update these forward looking statements.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
AGMQKKDBABKDQON
Date   Source Headline
8th Apr 20269:54 amRNSForm 8.5 (EPT/RI)
7th Apr 202611:44 amRNSForm 8.3 - Checkit plc
7th Apr 202610:30 amRNSForm 8.5 (EPT/RI)
1st Apr 202610:37 amRNSForm 8.5 (EPT/RI)
1st Apr 20269:38 amRNSForm 8.3 - Checkit PLC
1st Apr 20267:47 amRNSForm 8 (OPD) - Checkit plc
31st Mar 20262:50 pmEQSForm 8.3 - Checkit PLC
31st Mar 202611:29 amRNSForm 8.3 - Checkit plc
31st Mar 202611:12 amRNSHolding(s) in Company
31st Mar 202610:51 amRNSForm 8.5 (EPT/RI)
30th Mar 20261:58 pmRNSForm 8.3 - Checkit plc
30th Mar 202610:14 amRNSForm 8.5 (EPT/RI)
27th Mar 20263:39 pmRNSForm 8.3 Check it
27th Mar 20262:43 pmRNSForm 8.3 - Checkit PLC
27th Mar 202611:44 amRNSForm 8.3 - Checkit plc
27th Mar 202611:36 amEQSForm 8.3 - Checkit PLC
27th Mar 202610:40 amRNSForm 8.5 (EPT/RI)
27th Mar 202610:32 amRNSCheckit Plc - Form 8.3
26th Mar 202610:26 amRNSForm 8.3 - Checkit PLC
26th Mar 20267:45 amRNSDisclosure Table
26th Mar 20267:00 amRNSCommencement of Formal Sale Process
19th Feb 20267:00 amRNSFY26 Trading Update
21st Jan 202611:34 amRNSHolding(s) in Company
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20257:00 amRNSDirector/PDMR Shareholding
28th Nov 20257:00 amRNSDirector/PDMR Shareholding
5th Nov 20257:00 amRNSDirector/PDMR Shareholding
4th Nov 20257:00 amRNSDirector/PDMR Shareholding
30th Oct 20251:00 pmRNSDirector/PDMR Shareholding
28th Oct 20257:00 amRNSDirector/PDMR Shareholding
13th Oct 20252:52 pmRNSGrant of options and PDMR dealing
25th Sep 20257:00 amRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSInterim Results
19th Jun 20252:36 pmRNSGrant of Options
5th Jun 20253:11 pmRNSResult of AGM
29th May 20257:00 amRNSPosting of Annual Report and Notice of AGM
22nd May 20257:00 amRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSFinal Results
17th Apr 20257:00 amRNSNotice of Results and Investor Presentation
8th Apr 20257:00 amRNSStrategic update
20th Mar 202512:31 pmRNSForm 8.5 (EPT/RI) - Amendment
20th Mar 202510:21 amRNSForm 8.5 (EPT/RI)
19th Mar 202512:02 pmRNSResult of General Meeting
18th Mar 20259:43 amRNSForm 8.5 (EPT/RI)
18th Mar 20259:23 amRNSForm 8.5 (EPT/NON-RI)
17th Mar 202512:01 pmRNSForm 8.5 (EPT/RI)
17th Mar 20258:56 amRNSForm 8.5 (EPT/NON-RI)
14th Mar 202511:57 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.